Discoid Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Discoid Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-01-24FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate manufactured by Ipca Laboratories Limited. The approval updates the p…
-
FDA approval · 2023-03-30FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxychloroquine sulfate filed by Teva Pharmaceuticals USA, Inc., marking an approved change u…
-
FDA approval · 2022-05-03FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for Plaquenil (hydroxychloroquine sulfate) submitted by Advanz Pharma (US) Corp. This action constit…
-
FDA approval · 2018-05-01FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for hydroxychloroquine sulfate (generic) from Dr. Reddy's Laboratories Inc. This approval authorizes marketin…
-
FDA approval · 2017-01-27FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for Plaquenil (hydroxychloroquine sulfate) from Advanz Pharma (US) Corp.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-20FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Aurobindo Pharma Limited.